Aggregation characteristics of non-aromatic polar amino acids and its association to amyloids

29 March 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Aggregation of amino acids to amyloid like structures is known to have implications in the pathophysiology of single amino acids based inborn-errors of metabolism (IEMs). Studying the aggregation properties of amino acids is of crucial interest also to understand the association of these IEMs to amyloid associated diseases. Hence, herein we have studied the self-assembly of different non-aromatic charged/uncharged polar amino acids namely L-Glutamine (Gln), L-Aspartic acid (Asp), L-Glutamic acid (Glu) L-Histidine (His), L-Arginine (Arg), L-Serine (Ser) and L-Threonine (Thr) whose amyloid characteristics have still not been explored by ageing them for varying time intervals from 0-15 days in aqueous solution. The structure formation by the self-assembly of these amino acids were then studies by microscopy., Notably, of all amino acids glutamine revealed amyloid like febrile morphologies as observed in case of aromatic amino acids. The MTT assay also revealed a relatively more cytotoxic nature of glutamine assemblies as compared to other amino acid aggregates and suggests it may have amyloid like characteristics. Along with Gln, Asp and Glu also revealed formation of some unique self-assembled structures. The thioflavin T assay suggests these aggregates may have amyloid nature. Hence, the aggregation studies of these amino acids may have important implication in the pathogenesis of disease caused by the accumulation of glutamine, aspargine and aspartic acid.

Keywords

amyloid
single amino acids
non aromatic
in-born errors of metabolism

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.